Doximity (NYSE:DOCS) Stock: Insider Kira Scherer Wampler Sells 2,000 Shares

Doximity, Inc. (NYSE:DOCS) Director Kira Wampler sold 2,000 shares of the business’s stock in a transaction that occurred on Monday, November 2nd. The shares were sold at an average price of $32.89, for a total transaction of $65,780.00. Following the completion of the transaction, the director owned 27,923 shares of the company’s stock, valued at $918,387.47. The trade was a 6.68% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Kira Scherer Wampler also recently made the following trade(s):

• On Thursday, October 1st, Kira Wampler sold 2,000 shares of Doximity stock. The stock was sold at an average price of $28.91, for a total transaction of $57,820.00.
• On Tuesday, August 25th, Kira Wampler sold 2,000 shares of Doximity stock. The stock was sold at an average price of $24.95, for a total transaction of $49,900.00.

Doximity Price Performance

NYSE:DOCS traded up $2.04 during mid-day trading on Wednesday, reaching $34.64. The stock had a trading volume of 2,999,775 shares, compared to its average volume of 2,855,932. Doximity, Inc. has a 12 month low of $17.15 and a 12 month high of $66.11. The stock has a market capitalization of $6.17 billion, a PE ratio of 35.82, a P/E/G ratio of 25.50 and a beta of 1.29. The stock has a 50-day simple moving average of $28.78 and a two-hundred day simple moving average of $25.59.

Doximity (NYSE:DOCS) last issued its earnings results on Thursday, August 6th. The company reported $0.29 earnings per share for the quarter, beating analysts’ consensus estimates of $0.16 by $0.13. Doximity had a return on equity of 18.06% and a net margin of 25.48%. The firm had revenue of $156.62 million for the quarter. During the same period in the prior year, the business posted $0.36 EPS. The company’s revenue for the quarter was up 7.3% compared to the same quarter last year. Equities analysts expect that Doximity, Inc. will post 0.74 EPS for the current year.

Analyst Ratings Changes

Several analysts recently weighed in on DOCS shares. Canaccord Genuity Group set a $36.00 price objective on Doximity in a research note on Friday, August 7th. Zacks Research raised Doximity from a “strong sell” rating to a “hold” rating in a research note on Monday, July 13th. Evercore set a $35.00 price target on shares of Doximity in a research note on Tuesday, September 29th. Truist Financial raised their price target on shares of Doximity from $19.00 to $24.00 and gave the company a “hold” rating in a research note on Thursday, August 13th. Finally, Barclays upped their price objective on shares of Doximity from $20.00 to $27.00 and gave the stock an “equal weight” rating in a research report on Friday, August 21st. Eight investment analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $30.73.

Key Headlines Impacting Doximity

Here are the key news stories impacting Doximity this week:

• Positive Sentiment: Valuation commentary points to potential upside: one article says a model sees about 53% upside, and another describes Doximity as roughly 3% undervalued following its DoseCheck and UpToDate rollout. These are model-based assessments, not guarantees or new company guidance. Earnings To Watch: Doximity Inc (DOCS) Q2 2027 — GF Value Sees 53% Upside Doximity Could Be 3% Undervalued Following DoseCheck And UpToDate Rollout
• Neutral Sentiment: Investors are looking ahead to Doximity’s fiscal Q2 2027 results for the quarter ended September 2026. The articles preview Wall Street estimates and key metrics but do not report results, so they provide no confirmed earnings surprise. Q2 Performance and Wall Street Estimates
• Negative Sentiment: Several law firms are publicizing a pending securities class action and a November 16, 2026 lead-plaintiff deadline. The complaint alleges Doximity overstated the Newsfeed product’s contribution to revenue growth and its competitive position; these are allegations, not established findings. Litigation can add uncertainty and reputational risk. DOCS Securities Class Action Deadline Alert

Institutional Investors Weigh In On Doximity

A number of hedge funds and other institutional investors have recently bought and sold shares of DOCS. Carmignac Gestion increased its holdings in Doximity by 127.8% in the 1st quarter. Carmignac Gestion now owns 4,311,997 shares of the company’s stock worth $100,480,000 after purchasing an additional 2,418,971 shares in the last quarter. Wellington Management Group LLP boosted its stake in shares of Doximity by 24.7% during the second quarter. Wellington Management Group LLP now owns 3,135,113 shares of the company’s stock valued at $65,022,000 after purchasing an additional 621,464 shares in the last quarter. Quantinno Capital Management LP boosted its stake in shares of Doximity by 420.5% during the first quarter. Quantinno Capital Management LP now owns 140,345 shares of the company’s stock valued at $3,270,000 after purchasing an additional 113,380 shares in the last quarter. Royal Bank of Canada grew its holdings in shares of Doximity by 28.4% during the first quarter. Royal Bank of Canada now owns 206,282 shares of the company’s stock worth $4,806,000 after purchasing an additional 45,618 shares during the last quarter. Finally, Assenagon Asset Management S.A. bought a new stake in shares of Doximity during the third quarter worth about $28,858,000. Institutional investors own 87.19% of the company’s stock.

About Doximity

Doximity, Inc operates a digital platform designed for medical professionals in the United States. Its network connects physicians, nurse practitioners, physician assistants, pharmacists and other healthcare professionals, providing tools for professional communication, collaboration and career development.

The company offers services including secure messaging, telehealth, digital faxing, physician scheduling and professional networking. Doximity also provides medical news and educational content, as well as recruiting and job-search resources for healthcare professionals.

Doximity generates additional revenue through digital marketing and engagement solutions for pharmaceutical companies, healthcare organizations and health systems.